dr. eckhardt on the role of regorafenib in colorectal cancer
Published 10 years ago • 60 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
9:34
regorafenib in colorectal cancer
-
1:50
dr. eckhardt discusses angiogenesis inhibitors in mcrc
-
2:01
dr. holcombe on the progress of colorectal cancer and regorafenib
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
5:31
practical advice for using regorafenib
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:05
dr. corcoran on the utility of regorafenib in crc